| 2026-02-11 |
详情>>
内部人交易：
Zerillo Jeffrey股份减少1000.00股
|
| 2026-02-05 |
详情>>
股本变动：
变动后总股本4731.87万股
|
| 2026-02-05 |
详情>>
业绩披露：
2026年三季报(累计)每股收益2.80美元,归母净利润1.36亿美元,同比去年增长-17.09%
|
| 2026-02-05 |
财报披露：
美东时间 2026-02-05 盘前发布财报
|
| 2025-11-06 |
详情>>
业绩披露：
2026年中报每股收益1.82美元,归母净利润8967.70万美元,同比去年增长-13.31%
|
| 2025-08-07 |
详情>>
业绩披露：
2026年一季报每股收益0.96美元,归母净利润4746.60万美元,同比去年增长-3.26%
|
| 2025-06-27 |
股东大会：
将于2025-08-05召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors nominated by the Board of Directors and named in the accompanying Proxy Statement to serve until the 2026 Annual Meeting of Stockholders or until their earlier death, removal or resignation
2.To conduct an advisory vote to approve the compensation of our named executive officers
3.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal year ending March 31, 2026
|
| 2025-05-09 |
详情>>
业绩披露：
2023年年报每股收益-1.65美元,归母净利润-8230.6万美元,同比去年增长-140.07%
|
| 2025-05-09 |
详情>>
业绩披露：
2025年年报每股收益4.32美元,归母净利润2.15亿美元,同比去年增长2.52%
|
| 2025-02-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益3.31美元,归母净利润1.64亿美元,同比去年增长2.87%
|
| 2024-11-07 |
详情>>
业绩披露：
2025年中报每股收益2.08美元,归母净利润1.03亿美元,同比去年增长-3.17%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年中报每股收益2.15美元,归母净利润1.07亿美元,同比去年增长0.51%
|
| 2024-08-08 |
详情>>
业绩披露：
2025年一季报每股收益0.98美元,归母净利润4906.80万美元,同比去年增长-7.9%
|
| 2024-07-05 |
股东大会：
将于2024-08-06召开股东大会
会议内容 ▼▲
- 1.Elect the seven directors nominated by the Board of Directors and named in the accompanying Proxy Statement to serve until the 2025 Annual Meeting of Stockholders or until their earlier death, removal or resignation
2.Ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal year ending March 31, 2025
3.Conduct an advisory vote to approve the compensation of our named executive officers
4.Approve a proposal for the Amendment to our Amended and Restated Certificate of Incorporation
5.Conduct other business as may properly be brought before the 2024 Annual Meeting of Stockholders or any adjournment or postponement thereof, including proposals to adjourn or postpone the meeting
|
| 2024-05-15 |
详情>>
业绩披露：
2024年年报每股收益4.21美元,归母净利润2.09亿美元,同比去年增长354.34%
|
| 2024-02-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益3.21美元,归母净利润1.60亿美元,同比去年增长1.03%
|
| 2023-06-29 |
股东大会：
将于2023-08-01召开股东大会
会议内容 ▼▲
- 1.Elect the seven directors nominated by the Board of Directors and named in the accompanying Proxy Statement to serve until the 2024 Annual Meeting of Stockholders or until their earlier death, removal or resignation
2.Ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal year ending March 31, 2024
3.Conduct an advisory vote to approve the compensation of our named executive officers
4.Conduct an advisory vote to approve the preferred frequency of the advisory vote on compensation of our named executive officers
5.Conduct other business as may properly be brought before the Annual Meeting or any adjournment or postponement thereof, including proposals to adjourn or postpone the meeting
|
| 2022-06-28 |
股东大会：
将于2022-08-02召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors nominated by the Board of Directors and named in the accompanying Proxy Statement to serve until the 2023 Annual Meeting of Stockholders or until their earlier death, removal or resignation
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal year ending March 31, 2023
3.To vote on a non-binding resolution to approve the compensation of our named executive officers as disclosed in our Proxy Statement
4.To conduct other business as may properly be brought before the Annual Meeting or any adjournment or postponement thereof, including proposals to adjourn or postpone the meeting
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-29 |
股东大会：
将于2021-08-03召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors nominated by the Board of Directors and named in the accompanying Proxy Statement to serve until the 2022 Annual Meeting of Stockholders or until their earlier death, removal or resignation
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal year ending March 31, 2022
3.To vote on a non-binding resolution to approve the compensation of our named executive officers as disclosed in our Proxy Statement
4.To conduct other business as may properly be brought before the Annual Meeting or any adjournment or postponement thereof, including proposals to adjourn or postpone the meeting
|
| 2020-06-29 |
股东大会：
将于2020-08-04召开股东大会
会议内容 ▼▲
- 1.the election of the eight directors nominated by the Board of Directors and named in our Proxy Statement;
2.the ratification of the appointment of our independent registered public accounting firm for 2021;
3.a non-binding resolution to approve the compensation of our named executive officers as disclosed in our Proxy Statement;
4.the approval of our 2020 Long-Term Incentive Plan.
|
| 2019-06-28 |
股东大会：
将于2019-07-30召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors nominated by the Board of Directors and named in the accompanying Proxy Statement to serve until the 2020 Annual Meeting of Stockholders or until their earlier death, removal or resignation;
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal year ending March 31, 2020;
3.To vote on a non-binding resolution to approve the compensation of our named executive officers as disclosed in our Proxy Statement;
4.To conduct other business as may properly be brought before the Annual Meeting or any adjournment or postponement thereof, including proposals to adjourn or postpone the meeting.
|
| 2018-06-29 |
股东大会：
将于2018-07-31召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors nominated by the Board of Directors and named in the accompanying Proxy Statement to serve until the 2019 Annual Meeting of Stockholders or until their earlier death, removal or resignation;
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Brands Holdings, Inc. for the fiscal year ending March 31, 2019;
3.To vote on a non-binding resolution to approve the compensation of our named executive officers as disclosed in our Proxy Statement;
4.To conduct other business as may properly be brought before the Annual Meeting or any adjournment or postponement thereof, including proposals to adjourn or postpone the meeting.
|
| 2017-06-30 |
股东大会：
将于2017-08-01召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors nominated by the Board of Directors and named in the accompanying Proxy Statement to serve until the 2018 Annual Meeting of Stockholders or until their earlier death, removal or resignation;
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Brands Holdings, Inc. for the fiscal year ending March 31, 2018;
3.To vote on a non-binding resolution to approve the compensation of our named executive officers as disclosed in our Proxy Statement;
4.To vote on a non-binding proposal as to the frequency with which stockholders will vote on the compensation of our named executive officers in future years;
5.To conduct other business as may properly be brought before the Annual Meeting or any adjournment or postponement thereof, including proposals to adjourn or postpone the meeting.
|
| 2016-06-30 |
股东大会：
将于2016-08-02召开股东大会
会议内容 ▼▲
- 1. To elect the seven directors nominated by the Board of Directors and named in the accompanying Proxy Statement to serve until the 2017 Annual Meeting of Stockholders or until their earlier death, removal or resignation;
2. To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Brands Holdings, Inc. for the fiscal year ending March 31, 2017;
3. To vote on a non-binding resolution to approve the compensation of our named executive officers as disclosed in our Proxy Statement;
4. To conduct other business as may properly be brought before the Annual Meeting or any adjournment or postponement thereof, including proposals to adjourn or postpone the meeting.
|
| 2015-07-02 |
股东大会：
将于2015-08-04召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors nominated by the Board of Directors and named in the accompanying Proxy Statement to serve until the 2016 Annual Meeting of Stockholders or until their earlier death, removal or resignation;
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Brands Holdings, Inc. for the fiscal year ending March 31, 2016;
3.To vote on a non-binding resolution to approve the compensation of our named executive officers as disclosed in our Proxy Statement;
4.To conduct other business as may properly be brought before the Annual Meeting or any adjournment or postponement thereof, including proposals to adjourn or postpone the meeting.
|
| 2013-12-17 |
除权日：
美东时间 2013-12-27 每股派息0.31美元
|